Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation.
Kuang P, Liu T, Pan L, Zhu H, Wu Y, Ye Y, Xiang B, Ma H, Chang H, Niu T, Cui X, He C, Li J, Ji J, Huang J, Dong T, Dai Y, Lu X, Qing S, Wu H, Liang X, Wang X, Wu C.
Kuang P, et al. Among authors: wu y, wu h, wu c.
Leuk Lymphoma. 2016 Oct;57(10):2321-9. doi: 10.3109/10428194.2016.1144882. Epub 2016 Feb 16.
Leuk Lymphoma. 2016.
PMID: 26879808